PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
מצבים רפואיים
Recurrent Nasopharyngeal Carcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Peking University Third Hospital, Beijing, China
Contact: Study coordinator (Suqing Tian)Sichuan Cancer Hospital, Chengdu, China
Contact: Study coordinator (Shun Lu)Fujian Province Cancer Hospital, Fuzhou, China
Contact: Study coordinator (Shaojun Lin)Guizhou Cancer Hospital, Guiyang, China
Contact: Study coordinator (Feng Jin)Zhejiang Cancer Hospital, Hangzhou, China
Contact: Study coordinator (Xiaozhong Chen)Jiangxi Cancer Hospital, Nanchang, China
Contact: Study coordinator (Jingao Li)The First Affiliated Hospital of Guangxi Medical University, Nanning, China
Contact: Study coordinator (Rengshen Wang)Fudan University Shanghai Cancer Center, Shanghai, China
Contact: Study coordinator (Chaosu Hu)Zhongnan Hospital of Wuhan University, Wuhan, China
Contact: Study coordinator (Conghua Xie)Xijing Hospital, Xi'an, China
Contact: Study coordinator (Mei Shi)The First Affiliated Hospital of Xiamen University, Xiamen, China
Contact: Study coordinator (Qin Lin)
מובילי המחקר
Chong Zhao
Principal Investigator
Sun Yat-Sen University Cancer Center